Biontech is the first company to approve a vaccine based on the newest mRNA technology. About a story that doesn’t end there.
By Elisabeth Dostert, Frankfurt
Özlem Türeci and Uğur Şahin still haven’t got used to the applause. The co-founders of the Biontech company stand on the stage of the Literaturhaus Frankfurt and let their eyes wander over the audience. They are smiling – and yet they seem to want to leave the stage very quickly. You just mentioned the book “Project Lightspeed” that reporter Joe Miller wrote about and with you. He tells how they got approval for the Comirnaty coronavirus vaccine in less than a year. The roughly 120 tickets for the event sold out as quickly as if they were tickets to a pop star concert.